Search
ChatPaper
AI Writing
analysis
Analysis
编组
Open Data
more
More
RankingsMust ReadingJournal&ConferenceAI TRAI HistoryMaster Reading TreeXiaomai's Star TalentsTrajectoryTalentNDI TrackerOpenAI sign Language
VIPCreated with Sketch.

Intravenous cangrelor vs oral ticagrelor in patients with acute ST-segment elevation myocardial infarction undergoing primary percutaneous intervention: A randomised controlled trial

Salahaddin Ubaid,Thomas J Ford,Colin Berry,Benjamin Wrigley,Mark Thomas,Heather Murray, J Vickers, Armesilla,Jon Townend,Saib Khogali,Shahzad Munir,Joe Martins, R Jaumdally,Elisa J McAlindon,James M Cotton

Clinical Medicine（2019）

Cited 0|Views54
No score
Abstract
Despite advances in ST-segment elevation myocardial infarction (STEMI) treatment, a sizeable minority of patients suffer poor outcomes even when treated with timely primary percutaneous intervention (PPCI). More potent P2Y12 inhibition improves clinical outcomes, however, oral agents have a slow
More
Translated text
Key words
intravenous cangrelor,oral ticagrelor,myocardial infarction,primary percutaneous intervention,st-segment
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined